US2005256430A1PendingUtilityA1
Device and method for examining a body lumen
Est. expiryJul 12, 2021(expired)· nominal 20-yr term from priority
Inventors:Shlomo LewkowiczDaniel GatYehudit KraizerZvika GiladDavid LeuwGavriel MeronArkady GlukhovskyHoward Manten
A61B 5/073A61B 5/06A61B 5/061A61B 2562/08A61B 5/14539A61B 1/041A61B 5/062
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An in vivo examining device and method are described. The in vivo examining device has two operational phases; an initial phase in which the device is of initial dimensions and a final phase in which the device is of final dimensions. In the initial phase the device can pass freely through a normally configured body lumen whereas it may not be able to pass freely through an abnormally configured lumen. In the final phase the device can pass freely through a body lumen even if it is abnormally configured.
Claims
exact text as granted — not AI-modified1 . A method for controlled release of a substance in a gastrointestinal tract, the method comprising:
ingesting a device, said device comprising:
the substance;
a dissolvable body;
a dissolvable plug affixed to the body, said body and plug defining a closed receptacle; and
an essentially impermeable outer coating enclosing the plug and the body, said coating covering less than the entire plug.
2 . The method according to claim 1 , wherein the substance is a medicament.
3 . The method according to claim 1 , wherein the substance is a market.
4 . The method according to claim 1 , comprising releasing said substance in a specific site.
5 . The method according to claim 5 , wherein said site is a stricture.
6 . The method according to claim 1 , comprising monitoring said device.
7 . An in vivo device for controlled release of a substance in a gastrointestinal tract, the device comprising:
the substance; a dissolvable body; a dissolvable plug affixed to the body, said body and said plug defining a closed receptacle; and an essentially impermeable outer coating enclosing the plug and said body, said coating covering less than the entire plug.
8 . The in vivo device according to claim 7 , wherein the substance is enclosed in the receptacle.
9 . The in vivo device according to claim 7 wherein the dissolvable body includes the substance.
10 . The device according to claim 7 , wherein at least a first substance is dispersed within the plug and at least a second substance is enclosed in the receptacle
11 . The device according to claim 7 , wherein the substance is a medicament
12 . The device according to claim 7 , wherein the substance is a marker.
13 . The device according to claim 7 , comprising a monitoring device.
14 . The device according to claim 13 , wherein the monitoring device is a passive device.
15 . A method for controlled release of a substance in a gastrointestinal tract, the method comprising:
introducing into the gastrointestinal tract a device, said device comprising:
a dissolvable filling mixed with the substance;
a coating, partially coating said dissolvable filling, wherein the coating has initial dimensions that ate changeable to final dimensions; and
a monitoring device.
16 . The method according to claim 15 , comprising releasing said substance during a transition of said coating from said initial dimensions to said final dimensions.
17 . The method according to claim 15 , comprising externally controlling a transition of said coating from said initial dimensions to said final dimensions.
18 . The method according to claim 15 , comprising releasing said substance after a predetermined period.
19 . The method according to claim 15 , wherein the substance is a medicament.
20 . The method according to claim 15 , wherein the substance is a marker.
21 . The method according to claim 15 , wherein the monitoring device is an electronic ID tag.Join the waitlist — get patent alerts
Track US2005256430A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.